Elevation Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 5.99 M | $3.37 M | 0.00% | 10.14% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 4.76 M | $2.68 M | 0.00% | 8.05% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 3.53 M | $1.98 M | 0.00% | 5.97% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.16 M | $1.78 M | 8.88% | 5.35% |
| BVF INC/IL | 02/14/2025 | 2.97 M | $1.67 M | 0.00% | 5.02% |
| AISLING CAPITAL MANAGEMENT LP | 02/12/2025 | 2.83 M | $1.59 M | 0.00% | 4.80% |
| VANGUARD GROUP INC | 02/11/2025 | 2.61 M | $1.47 M | -15.03% | 4.42% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.65 M | $929,259 | -58.59% | 2.79% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.60 M | $902,022 | -10.23% | 2.71% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.16 M | $651,364 | 4.28% | 1.96% |
| STATE STREET CORP | 02/14/2025 | 1.07 M | $603,041 | 5.29% | 1.81% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 1.02 M | $573,043 | -5.67% | 1.72% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 941,275 | $529,561 | 0.00% | 1.59% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 815,916 | $459,034 | 3.88% | 1.38% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 690,050 | $388,222 | -0.01% | 1.17% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 444,039 | $249,816 | 0.81% | 0.75% |
| ALLOSTERY INVESTMENTS LP | 02/14/2025 | 432,206 | $243,159 | 100.00% | 0.73% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 333,300 | $187,514 | -38.65% | 0.56% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 215,950 | $121,493 | -0.02% | 0.37% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 200,000 | $112,520 | 100.00% | 0.34% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 188,771 | $105,712 | 550.49% | 0.32% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 183,454 | $103,211 | -0.02% | 0.31% |
| JPMORGAN CHASE & CO | 02/12/2025 | 180,375 | $101,478 | 194.09% | 0.31% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 174,137 | $97,970 | 0.00% | 0.29% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 166,305 | $93,000 | -74.50% | 0.28% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 124,181 | $69,864 | 0.00% | 0.21% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 123,840 | $69,672 | 0.00% | 0.21% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 95,963 | $53,989 | -25.03% | 0.16% |
| UBS GROUP AG | 02/14/2025 | 88,630 | $49,899 | 108.10% | 0.15% |
| BARCLAYS PLC | 02/13/2025 | 87,608 | $49,000 | 21.55% | 0.15% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 84,400 | $47,483 | 47.81% | 0.14% |
| JANE STREET GROUP, LLC | 02/14/2025 | 70,883 | $39,879 | 138.92% | 0.12% |
| RHUMBLINE ADVISERS | 01/30/2025 | 70,035 | $39,420 | 8.40% | 0.12% |
| PALUMBO WEALTH MANAGEMENT LLC | 01/30/2025 | 69,105 | $38,879 | 294.55% | 0.12% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 63,974 | $36,000 | 100.00% | 0.11% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 62,380 | $35,095 | 100.00% | 0.11% |
| MILLINGTON FINANCIAL ADVISORS, LLC | 02/04/2025 | 50,000 | $32,005 | -50.00% | 0.08% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 45,000 | $25,317 | 100.00% | 0.08% |
| CITIGROUP INC | 02/12/2025 | 44,732 | $25,167 | 12.70% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 37,925 | $21,337 | 100.00% | 0.06% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 29,025 | $16,329 | 51.44% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 28,058 | $15,785 | 0.58% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 28,029 | $15,769 | 5.02% | 0.05% |
| INVESCO LTD. | 02/13/2025 | 24,795 | $13,949 | 1.84% | 0.04% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 24,217 | $13,624 | 128.59% | 0.04% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 02/10/2025 | 20,213 | $11,372 | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 17,727 | $9,980 | 29.61% | 0.03% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 16,841 | $10,000 | 0.00% | 0.03% |
| FMR LLC | 02/13/2025 | 16,441 | $9,250 | 69.20% | 0.03% |
| PROSHARE ADVISORS LLC | 02/14/2025 | 15,894 | $8,942 | 100.00% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Elevation Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 79 institutional investors and hedge funds held shares of Elevation Oncology, Inc.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 5.99 M
TANG CAPITAL MANAGEMENT LLC: 4.76 M
FARALLON CAPITAL MANAGEMENT LLC: 3.53 M
BlackRock Funding, Inc. /DE: 3.16 M
BVF INC/IL: 2.97 M
Aisling Capital Management LP: 2.83 M
67.63% of Elevation Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 42.59 M shares in the last 24 months. This purchase volume represents approximately $35.77 M in transactions.